Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Amsterdam
- Most recent report
- 8-K, filed Sep 2, 2026
- Filings on record
- 947 filings
- On EDGAR
- CIK 1590560
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 92
News 8 of 153
Prospectuses and Registrations 8 of 42
- S-8 Registration statement for an employee plan Jul 29, 2026
- 424B5 Prospectus supplement for an offering Jun 24, 2026
- 424B5 Prospectus supplement for an offering Jun 22, 2026
- 424B5 Prospectus supplement for an offering Sep 29, 2025
- 424B5 Prospectus supplement for an offering Sep 24, 2025
- 424B5 Prospectus supplement for an offering Jul 29, 2025
- S-8 Registration statement for an employee plan Jun 30, 2025
- 424B5 Prospectus supplement for an offering Jan 8, 2025
Proxies 8 of 32
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 16, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- PRE 14A Preliminary proxy statement Apr 16, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
Ownership 8 of 583
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 20, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 16, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 2, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
Other 8 of 45
- ARS Annual report sent to shareholders Apr 27, 2026
- ARS Annual report sent to shareholders Apr 28, 2025
- ARS Annual report sent to shareholders May 1, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- CT ORDER Jun 29, 2021
- SEC STAFF LETTER Mar 5, 2020
- SEC STAFF LETTER Feb 6, 2020
- UPLOAD Comment letter from SEC staff Nov 26, 2019
Everything here comes from uniQure N.V.'s own filings on SEC EDGAR. The filing list is rechecked every hour.